LumaMed
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology (NCT02207179) | LumaMed | 2014-01-01 |
Track LumaMed automatically
Every clearance here is in the API, with alerts when new ones post.